# A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

> **NCT00465517** · PHASE2 · COMPLETED · sponsor: **Marinus Pharmaceuticals** · enrollment: 147 (actual)

## Conditions studied

- Partial Epilepsy
- Catamenial Epilepsy

## Interventions

- **DRUG:** Ganaxolone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00465517
- **Lead sponsor:** Marinus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465517, "A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00465517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*